Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2025-08-14 2025-08-14
Drug Identification Number 02241797 02241797
Brand name PROCYTOX PROCYTOX
Common or Proper name Cyclophosphamide for Injection Cyclophosphamide for Injection
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients CYCLOPHOSPHAMIDE CYCLOPHOSPHAMIDE
Strength(s) 200MG 200MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 200mg / 20mL vial (Prod. Code 2638B5039) 200mg / 20mL vial (Prod. Code 2638B5039)
ATC code L01AA L01AA
ATC description ALKYLATINGAGENTS ALKYLATINGAGENTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2026-12-31 2026-12-31
Actual discontinuation date
Remaining supply date
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments If you have any questions regarding this communication, please do not hesitate to contact your BAXTER Pharmaceuticals Territory Manager or your BAXTER Customer Care team at 1.888.719.9955 If you have any questions regarding this communication, please do not hesitate to contact your BAXTER Pharmaceuticals Territory Manager or your BAXTER Customer Care team at 1.888.719.9955
Health Canada comments